206 related articles for article (PubMed ID: 33079779)
1. Systematic review and meta-analysis: risks of postoperative complications with preoperative use of anti-tumor necrosis factor-alpha biologics in inflammatory bowel disease patients.
Moosvi Z; Duong J; Bechtold ML; Nguyen DL
Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):799-816. PubMed ID: 33079779
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD.
Moosvi Z; Duong JT; Bechtold ML; Nguyen DL
South Med J; 2021 Feb; 114(2):98-105. PubMed ID: 33537791
[TBL] [Abstract][Full Text] [Related]
3. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
[TBL] [Abstract][Full Text] [Related]
4. Safety Analysis of Preoperative Anti-TNF-α Therapy in Pediatric IBD After Intestinal Resection: A Systematic Review and Meta-analysis.
Bajzát D; Kéri AF; Imrei M; Kói T; Párniczky A; Hegyi P; Kovács K; Váncsa S; Müller KE
Inflamm Bowel Dis; 2023 Dec; 29(12):1971-1980. PubMed ID: 36789751
[TBL] [Abstract][Full Text] [Related]
5. Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-Analysis.
Hanzel J; Almradi A; Istl AC; Yang ML; Fleshner KA; Parker CE; Guizzetti L; Ma C; Singh S; Jairath V
Dig Dis Sci; 2022 Feb; 67(2):646-660. PubMed ID: 33634430
[TBL] [Abstract][Full Text] [Related]
6. Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience.
Rizzo G; Armuzzi A; Pugliese D; Verbo A; Papa A; Mattana C; Rapaccini GL; Guidi L; Coco C
Int J Colorectal Dis; 2011 Nov; 26(11):1435-44. PubMed ID: 21594668
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Cira K; Weber MC; Wilhelm D; Friess H; Reischl S; Neumann PA
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498459
[TBL] [Abstract][Full Text] [Related]
8. Associations Between Obesity and the Effectiveness of Anti-Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis.
Dai ZH; Xu XT; Ran ZH
Ann Pharmacother; 2020 Aug; 54(8):729-741. PubMed ID: 31955605
[No Abstract] [Full Text] [Related]
9. Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis.
Shah ED; Farida JP; Siegel CA; Chong K; Melmed GY
Inflamm Bowel Dis; 2017 Apr; 23(4):570-577. PubMed ID: 28230558
[TBL] [Abstract][Full Text] [Related]
10. Anti-TNF and Postoperative Complications in Abdominal Crohn's Disease Surgery.
Yamamoto T; Teixeira FV; Saad-Hossne R; Kotze PG; Danese S
Curr Drug Targets; 2019; 20(13):1339-1348. PubMed ID: 30947671
[TBL] [Abstract][Full Text] [Related]
11. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
12. The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease.
Nguyen GC; Elnahas A; Jackson TD
J Crohns Colitis; 2014 Dec; 8(12):1661-7. PubMed ID: 25107847
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.
Huguet M; Pereira B; Goutte M; Goutorbe F; Dubois A; Bommelaer G; Buisson A
Inflamm Bowel Dis; 2018 Jan; 24(2):261-268. PubMed ID: 29361101
[TBL] [Abstract][Full Text] [Related]
14. Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease.
Yung DE; Horesh N; Lightner AL; Ben-Horin S; Eliakim R; Koulaouzidis A; Kopylov U
Inflamm Bowel Dis; 2018 Oct; 24(11):2327-2338. PubMed ID: 29788385
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease.
Law CCY; Narula A; Lightner AL; McKenna NP; Colombel JF; Narula N
J Crohns Colitis; 2018 Apr; 12(5):538-545. PubMed ID: 29718245
[TBL] [Abstract][Full Text] [Related]
16. Impact of Biologics and Small-Molecule Agents on Postoperative Complications in IBD: A Systematic Review.
Lee KE; Sizemore JA; Kim G; Shen B; Sands BE
Dis Colon Rectum; 2024 Jun; 67(S1):S11-S25. PubMed ID: 38294838
[TBL] [Abstract][Full Text] [Related]
17. The incidence, clinical characteristics and serological characteristics of anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: A systematic review and meta-analysis.
Dai C; Wang YN; Tian WN; Huang YH; Jiang M
Int Immunopharmacol; 2022 Nov; 112():109269. PubMed ID: 36182873
[TBL] [Abstract][Full Text] [Related]
18. Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis.
Bertucci Zoccali M; Hyman NH; Skowron KB; Rubin M; Cannon LM; Hurst RD; Umanskiy K; Rubin DT; Shogan BD
Dis Colon Rectum; 2019 Nov; 62(11):1344-1351. PubMed ID: 31596761
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis.
Zittan E; Milgrom R; Ma GW; Wong-Chong N; OʼConnor B; McLeod RS; MacRae HM; Greenberg GR; Nguyen GC; Croitoru K; Steinhart AH; Cohen Z; Silverberg MS
Inflamm Bowel Dis; 2016 Oct; 22(10):2442-7. PubMed ID: 27607335
[TBL] [Abstract][Full Text] [Related]
20. Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
Yamada A; Komaki Y; Patel N; Komaki F; Aelvoet AS; Tran AL; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
Am J Gastroenterol; 2017 Sep; 112(9):1423-1429. PubMed ID: 28719595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
